Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Keytruda killer: Chipscreen bags Chinese rights to Biocytogen's bispecific antibody
Fierce Biotech
Tue, 02/28/23 - 09:56 am
cancer
Biocytogen
Chipscreen NewWay Biosciences
Merck
Keytruda
YH008
Warren urges US patent office to scrutinize Merck's efforts with Keytruda
Fierce Pharma
Thu, 02/23/23 - 04:25 pm
Merck
Keytruda
Senate
Elizabeth Warren
patents
Merck’s COVID-19 treatment falls short in prevention study
BioPharma Dive
Tue, 02/21/23 - 04:53 pm
Merck
COVID-19
Lagevrio
clinical trials
BioNTech touts differences with Moderna in race for cancer vaccines
Endpoints
Tue, 02/21/23 - 04:41 pm
BioNTech
Moderna Therapeutics
Merck
vaccines
cancer
cancer vaccines
Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’
BioPharma Dive
Tue, 02/21/23 - 11:05 am
Big Pharma
patents
patent cliff
biosimilars
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Opdivo
As HQ move nears completion, Merck finds a buyer for its sprawling Kenilworth campus
Fierce Pharma
Mon, 02/20/23 - 12:47 pm
Merck
New Jersey
headquarters
Merck seeks more approvals for infectious disease drug
Endpoints
Fri, 02/17/23 - 11:26 am
Merck
CMV
FDA
Prevymis
Merck targets BMS' stomach cancer head start with Keytruda win, but past failure casts shadow
Fierce Pharma
Thu, 02/16/23 - 04:54 pm
Merck
Keytruda
clinical trials
stomach cancer
Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris
BioSpace
Thu, 02/16/23 - 11:27 am
Seagen
earnings
Merck
M&A
Adcetris
After several flops, Merck exec stands by aggressive Keytruda prostate cancer program
Fierce Biotech
Thu, 02/16/23 - 11:06 am
Merck
Keytruda
prostate cancer
Merck, Glenmark headed to trial after judge scraps early dismissal bid in Zetia antitrust case
Fierce Pharma
Wed, 02/15/23 - 10:52 am
Merck
Glenmark
patents
pay-for-delay
legal
Zetia
Merck and Nectin to Study Novel Anti-PVR Candidate with Keytruda
BioSpace
Tue, 02/7/23 - 12:15 pm
Merck
Nectin Therapeutics
NTX1088
solid tumors
Led by Merck, Vertex and Lilly, pharma's share prices largely climbed in '22 despite economic angst
Fierce Pharma
Tue, 02/7/23 - 12:00 pm
Merck
Vertex Pharmaceuticals
Eli Lilly
pharma stocks
Merck Eyes Third Endometrial Cancer Nod for Keytruda
BioSpace
Fri, 02/3/23 - 10:30 am
Merck
Keyruda
clinical trials
endometrial cancer
Merck pill linked to new mutations, study says
Fierce Pharma
Thu, 02/2/23 - 11:15 pm
Merck
antivirals
COVID-19
Lagevrio
Q4 earnings roundup: Merck, Lilly, Takeda and BMS release financials
Medical Marketing and Media
Thu, 02/2/23 - 10:55 am
earnings
Merck
Takeda
Bristol Myers Squibb
Eli Lilly
The end of the Humira era
EP Vantage
Mon, 01/30/23 - 10:46 am
AbbVie
Humira
patents
biosimilars
Merck
Keytruda
Lilly enters ripe BTK field with quick FDA nod in mantle cell lymphoma
Endpoints
Sun, 01/29/23 - 02:14 pm
Eli Lilly
Btk inhibitors
FDA
Merck
mantle cell lymphoma
Jaypirca
Will This Billion-Dollar Acquisition Be a Smart Move for Merck?
Motley Fool
Fri, 01/27/23 - 10:47 am
Merck
M&A
Imago BioSciences
Construction on Merck's London research hub set to begin in April 2023
Endpoints
Wed, 01/25/23 - 10:40 pm
Merck
London
R&D
UK
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »